Rayonier rises 8.6% after earnings beat and $300 million buyback boost

What happened

Rayonier (RYN) rose 8.6% on November 5, 2026, because quarterly results beat estimates and the Board approved a $300 million increase to its share repurchase authorization. Rayonier reported third-quarter 2026 net income attributable to the company of $123.3 million, or $0.41 per diluted share, on sales of $565.6 million. That compared with net income of $43.2 million, or $0.28 per diluted share, on sales of $177.5 million in the year-ago quarter. The quarter included an item(s) totaling $90.6 million. Separately, Zacks reported Rayonier beat consensus EPS estimates with quarterly earnings of $0.13 per share versus the Zacks Consensus of $0.1, 26.3% above estimates.

How big was the move

The stock rose 8.6% to close at $21.91, a move that was 4.4 times a typical daily move for this stock. Volume was 1.7 times its 20-day average, indicating heavier trading than normal. The gain looked company-specific because earnings were released during the session. The broader market moved differently: the S&P 500 fell 4.4% on the day and fell 4.7% over the last five sessions, while the Real Estate sector median fell 1.6% on the day. Compared with its sector, the stock was 10.2 percentage points better than the sector median.

The technical picture

The stock traded above its short- and medium-term averages, sitting 14.1% above its 20-day moving average and 12.7% above its 50-day moving average, and 5.0% above its 200-day moving average. At the same time, the 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) stood at 73, above 70, a level often called overbought. The stock was 11.7% below the 52-week high. Over one month the stock rose 21.8%, over three months it rose 0.6%, and over one year it rose 0.6%, leaving it 8.0 percentage points behind the S&P 500 for the year. Volatility was elevated, at 31% annualized over 60 days, higher than 87% of its own readings over five years.

Fundamentals and valuation

For the four quarters through September 30, 2026, Rayonier reported revenue of $1.36 billion, which grew 24.1% from a year earlier despite a revenue growth one quarter earlier that showed a decline of 12.8%. Diluted earnings per share for that period were $0.61, a figure that fell 87.8% from a year earlier. Gross margin stood at 21.8% (a year earlier: 38.6%), and operating margin was 12.0% (a year earlier: 36.9%). Free-cash-flow margin was 17.2% and return on invested capital was 0.8%. On the balance sheet the company showed net debt of 3.6 times EBITDA. Share count over one year increased by 3.7%.

Valuation metrics show a premium to historical medians. The stock traded at 35.7 times trailing earnings, higher than 57% of its own readings over the past five years (five-year median: 32.5 times earnings). Price to forward earnings was 51.6 times expected earnings, with a free-cash-flow yield of 4.0%. PromtFinance scores rank the company 44 (Weak) for Value, 57 (Neutral) for Growth, 33 (Weak) for Quality, 65 (Positive) for Momentum, 67 (Positive) for Revisions, and 52 (Neutral) for Stability within the sector.

Earnings and analyst expectations

Rayonier reported on November 4, 2026, that quarterly earnings were $0.13 per share versus $0.10 expected, 26.3% above estimates. That marked six consecutive quarters beating estimates and an average surprise over the last four reports of 27.6% above estimates. The typical two-day reaction after recent reports had been modest, with the stock rising 0.8% on average in the two trading days after past announcements. Analysts covering the stock total 27, with a consensus rating of Hold; 33% of analysts rate the stock Buy or Strong Buy, and the consensus price target is $24.75, 13.0% above the closing price. The next scheduled report is February 10, 2027.

What to watch

• November 4, 2026: last report showing earnings per share of $0.13 against $0.10 expected, 26.3% above estimates
• Board approval of a $300 million increase to the existing share repurchase authorization, in addition to approximately $51 million remaining under the prior authorization as of October 30, 2026
• Next earnings report due February 10, 2027
• Net debt of 3.6 times EBITDA and share count increase of 3.7% over one year
• Price to forward earnings of 51.6 times expected earnings